Protective Efficacy of a Vaccine Using a -based Delivery System Expressing Omp3b, BCSP31, and SOD Proteins Against Brucellosis in Korean Black Goats
Overview
Affiliations
This study aimed to assess the protective efficacy of a novel vaccine formulation in goats. Twenty black goats were separated into 2 groups. Group A was injected with 3.0 × 10 CFU (colony-forming units)/mL of a -based delivery system harboring only vector (pMMP65). Group B was immunized with 3.0 × 10 CFU/mL of the vaccine, a mixture of 3 vaccine strains (using a -based delivery system) expressing each recombinant Omp3b, BCSP31, and SOD protein. No delivery strain was isolated from all tested lymph nodes and parenchymal organs. Serum immunoglobulin (Ig) G titers and interferon gamma concentrations were significantly higher in group B than those in group A. After intraconjunctival challenge with virulent strain 544, 40% of the vaccinated animals in group B were protected against infection. The infection index and colonization of in tested tissues was significantly lower in group B than group A. We conclude that this vaccine induces significant antigen-specific immune responses and provides effective protection against infection in goats. Further studies are needed to enhance the protection rate of this vaccine and to discover its practical application in small ruminants.
Recombinant Live-Attenuated Vaccine for Veterinary Use.
Chagas D, Santos F, de Oliveira N, Bohn T, Dellagostin O Vaccines (Basel). 2025; 12(12.
PMID: 39771981 PMC: 11680399. DOI: 10.3390/vaccines12121319.
Brucellosis detection and the role of spp. cell wall proteins.
Bulashev A, Eskendirova S Vet World. 2023; 16(7):1390-1399.
PMID: 37621538 PMC: 10446727. DOI: 10.14202/vetworld.2023.1390-1399.